commit | f2c11f7f2225e0a881585bf866ce5117f3c51735 | [log] [tgz] |
---|---|---|
author | Googler <lberki@google.com> | Thu Sep 28 05:03:31 2023 -0700 |
committer | Copybara-Service <copybara-worker@google.com> | Thu Sep 28 05:05:58 2023 -0700 |
tree | 042ad3340822e5950dd53afe7a56b44f8f308e33 | |
parent | 6bd26f5778ab7b0a7030fd5cc40e490e04f2ae9c [diff] |
Remove a number of graveyarded command line options. RELNOTES[INC]: The following previously no-op command line options are not available anymore: --legacy_spawn_scheduler, --use_workers_with_dexbuilder, --print_workspace_in_output_paths_if_needed, --watchos_simulator_version, --watchos_simulator_device, --tvos_simulator_version, --tvos_simulator_device. PiperOrigin-RevId: 569144295 Change-Id: I4fa45c5e040ce24fe337f515833a3c6a4dd679c3
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md